Effects of ramosetron on gastrointestinal transit of guinea pig

Yoo Mi Park, Young Ju Lee, Young Ho Lee, Tae Il Kim, Hyojin Park

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background/Aims A selective 5-hydroxytryptamine (5-HT) type 3 receptor antagonist, ramosetron, inhibits stress-induced abnormal defecation in animals and is currently used as a therapeutic drug for irritable bowel syndrome with diarrhea. The aim of this study is to investigate the effect of ramosetron on altered gastrointestinal (GI) transit. Methods Male guinea pigs weighing approximately 300 g were used. The effect of ramosetron was investigated on altered GI transit induced by thyrotropin-releasing hormone (TRH), 5-HT, or mustard oil (MO). GI transit was evaluated by the migration of charcoal mixture from the pylorus to the most distal point, and expressed as a percentage (%) of charcoal migration (cm) of the total length of total small intestine (cm). Results The average charcoal transit was 51.3 ± 20.1% in the control (vehicle) group, whereas in the ramosetron group charcoal moved 56.6 ± 21.9%, 46.9 ± 9.14% and 8.4 ± 5.6% of the total small intestine at the concentrations of 10, 30 and 100 μg/kg, respectively. GI transit after administration of TRH (100 μg/kg), 5-HT (10 mg/kg) or MO (10 mg/kg) was accelerated compared to vehicle (5-HT, 94.9 ± 9.22%; TRH, 73.4 ± 14.7%; MO, 81.0 ± 13.7%). Ramosetron inhibited GI transit altered by 5-HT, TRH or MO. Conclusions Ramosetron modulated GI transit. We suggest that ramosetron may be therapeutically useful for those with accelerated upper GI transit.

Original languageEnglish
Pages (from-to)36-41
Number of pages6
JournalJournal of Neurogastroenterology and Motility
Volume19
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Gastrointestinal Transit
Guinea Pigs
Charcoal
Thyrotropin-Releasing Hormone
Serotonin
Small Intestine
Receptors, Serotonin, 5-HT3
Defecation
Irritable Bowel Syndrome
Pylorus
ramosetron
Diarrhea
Control Groups
mustard oil

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Gastroenterology

Cite this

Park, Yoo Mi ; Lee, Young Ju ; Lee, Young Ho ; Kim, Tae Il ; Park, Hyojin. / Effects of ramosetron on gastrointestinal transit of guinea pig. In: Journal of Neurogastroenterology and Motility. 2013 ; Vol. 19, No. 1. pp. 36-41.
@article{3155cc0a3a43415181948a6ae1df398b,
title = "Effects of ramosetron on gastrointestinal transit of guinea pig",
abstract = "Background/Aims A selective 5-hydroxytryptamine (5-HT) type 3 receptor antagonist, ramosetron, inhibits stress-induced abnormal defecation in animals and is currently used as a therapeutic drug for irritable bowel syndrome with diarrhea. The aim of this study is to investigate the effect of ramosetron on altered gastrointestinal (GI) transit. Methods Male guinea pigs weighing approximately 300 g were used. The effect of ramosetron was investigated on altered GI transit induced by thyrotropin-releasing hormone (TRH), 5-HT, or mustard oil (MO). GI transit was evaluated by the migration of charcoal mixture from the pylorus to the most distal point, and expressed as a percentage ({\%}) of charcoal migration (cm) of the total length of total small intestine (cm). Results The average charcoal transit was 51.3 ± 20.1{\%} in the control (vehicle) group, whereas in the ramosetron group charcoal moved 56.6 ± 21.9{\%}, 46.9 ± 9.14{\%} and 8.4 ± 5.6{\%} of the total small intestine at the concentrations of 10, 30 and 100 μg/kg, respectively. GI transit after administration of TRH (100 μg/kg), 5-HT (10 mg/kg) or MO (10 mg/kg) was accelerated compared to vehicle (5-HT, 94.9 ± 9.22{\%}; TRH, 73.4 ± 14.7{\%}; MO, 81.0 ± 13.7{\%}). Ramosetron inhibited GI transit altered by 5-HT, TRH or MO. Conclusions Ramosetron modulated GI transit. We suggest that ramosetron may be therapeutically useful for those with accelerated upper GI transit.",
author = "Park, {Yoo Mi} and Lee, {Young Ju} and Lee, {Young Ho} and Kim, {Tae Il} and Hyojin Park",
year = "2013",
month = "1",
day = "1",
doi = "10.5056/jnm.2013.19.1.36",
language = "English",
volume = "19",
pages = "36--41",
journal = "Journal of Neurogastroenterology and Motility",
issn = "2093-0879",
publisher = "Korean Society of Neurogastroenterology and Motility",
number = "1",

}

Effects of ramosetron on gastrointestinal transit of guinea pig. / Park, Yoo Mi; Lee, Young Ju; Lee, Young Ho; Kim, Tae Il; Park, Hyojin.

In: Journal of Neurogastroenterology and Motility, Vol. 19, No. 1, 01.01.2013, p. 36-41.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of ramosetron on gastrointestinal transit of guinea pig

AU - Park, Yoo Mi

AU - Lee, Young Ju

AU - Lee, Young Ho

AU - Kim, Tae Il

AU - Park, Hyojin

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background/Aims A selective 5-hydroxytryptamine (5-HT) type 3 receptor antagonist, ramosetron, inhibits stress-induced abnormal defecation in animals and is currently used as a therapeutic drug for irritable bowel syndrome with diarrhea. The aim of this study is to investigate the effect of ramosetron on altered gastrointestinal (GI) transit. Methods Male guinea pigs weighing approximately 300 g were used. The effect of ramosetron was investigated on altered GI transit induced by thyrotropin-releasing hormone (TRH), 5-HT, or mustard oil (MO). GI transit was evaluated by the migration of charcoal mixture from the pylorus to the most distal point, and expressed as a percentage (%) of charcoal migration (cm) of the total length of total small intestine (cm). Results The average charcoal transit was 51.3 ± 20.1% in the control (vehicle) group, whereas in the ramosetron group charcoal moved 56.6 ± 21.9%, 46.9 ± 9.14% and 8.4 ± 5.6% of the total small intestine at the concentrations of 10, 30 and 100 μg/kg, respectively. GI transit after administration of TRH (100 μg/kg), 5-HT (10 mg/kg) or MO (10 mg/kg) was accelerated compared to vehicle (5-HT, 94.9 ± 9.22%; TRH, 73.4 ± 14.7%; MO, 81.0 ± 13.7%). Ramosetron inhibited GI transit altered by 5-HT, TRH or MO. Conclusions Ramosetron modulated GI transit. We suggest that ramosetron may be therapeutically useful for those with accelerated upper GI transit.

AB - Background/Aims A selective 5-hydroxytryptamine (5-HT) type 3 receptor antagonist, ramosetron, inhibits stress-induced abnormal defecation in animals and is currently used as a therapeutic drug for irritable bowel syndrome with diarrhea. The aim of this study is to investigate the effect of ramosetron on altered gastrointestinal (GI) transit. Methods Male guinea pigs weighing approximately 300 g were used. The effect of ramosetron was investigated on altered GI transit induced by thyrotropin-releasing hormone (TRH), 5-HT, or mustard oil (MO). GI transit was evaluated by the migration of charcoal mixture from the pylorus to the most distal point, and expressed as a percentage (%) of charcoal migration (cm) of the total length of total small intestine (cm). Results The average charcoal transit was 51.3 ± 20.1% in the control (vehicle) group, whereas in the ramosetron group charcoal moved 56.6 ± 21.9%, 46.9 ± 9.14% and 8.4 ± 5.6% of the total small intestine at the concentrations of 10, 30 and 100 μg/kg, respectively. GI transit after administration of TRH (100 μg/kg), 5-HT (10 mg/kg) or MO (10 mg/kg) was accelerated compared to vehicle (5-HT, 94.9 ± 9.22%; TRH, 73.4 ± 14.7%; MO, 81.0 ± 13.7%). Ramosetron inhibited GI transit altered by 5-HT, TRH or MO. Conclusions Ramosetron modulated GI transit. We suggest that ramosetron may be therapeutically useful for those with accelerated upper GI transit.

UR - http://www.scopus.com/inward/record.url?scp=84876702394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876702394&partnerID=8YFLogxK

U2 - 10.5056/jnm.2013.19.1.36

DO - 10.5056/jnm.2013.19.1.36

M3 - Article

C2 - 23350045

AN - SCOPUS:84876702394

VL - 19

SP - 36

EP - 41

JO - Journal of Neurogastroenterology and Motility

JF - Journal of Neurogastroenterology and Motility

SN - 2093-0879

IS - 1

ER -